[Executive summary of the guidelines on the diagnosis and treatment of acute heart failure].

Guidelines and Expert Consensus documents aim to present all the relevant evidence on a particular issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical decision-making. A great number of Guidelines and Expert Consensus Documents have been issued in recent years by the European Society of Cardiology (ESC) and by different organizations and other related societies. This profusion can put at stake the authority and validity of guidelines, which can only be guaranteed if they have been developed by an unquestionable decision-making process. This is one of the reasons why the ESC and others have issued recommendations for formulating and issuing Guidelines and Expert Consensus Documents. In spite of the fact that standards for issuing good quality Guidelines and Expert Consensus Documents are well defined, recent surveys of Guidelines and Expert Consensus Documents published in peer-reviewed journals between 1985 and 1998 have shown that methodological standards were not complied with in the vast majority of cases. It is therefore of great importance that guidelines and recommendations are presented in formats that are easily interpreted. Subsequently, their implementation programmes must also be well conducted. Attempts have been made to determine whether guidelines improve the quality of clinical practice and the utilization of health resources. The ESC Committee for Practice Guidelines (CPG) supervises and coordinates the preparation of new Guidelines and Expert Consensus Documents produced by Task Forces, expert groups or consensus panels. The chosen experts in these writing panels are asked to provide disclosure statements of all relationships they may have which might be perceived as real or potential conflicts of interest. These disclosure forms are kept on file at the European Heart House, headquarters of the ESC. The Committee is also responsible for the …

[1]  The Electrocardiographic Sign of Acute Hemopericardium , 1962, Circulation.

[2]  SODIUM DIURESIS PRODUCED BY DOPAMINE IN PATIENTS WITH CONGESTIVE HEART FAILURE. , 1963, The New England journal of medicine.

[3]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.

[4]  R. Russell,et al.  Hemodynamic Evaluation of Left Ventricular Function in Shock Complicating Myocardial Infarction , 1972, Circulation.

[5]  K. Rosen,et al.  Effects of Ouabain on Impaired Left Ventricular Function in Acute Myocardial Infarction , 1972 .

[6]  J. Kastor,et al.  Pacing in acute myocardial infarction--indications, methods, hazards, and results. , 1975, Cardiovascular clinics.

[7]  A. DeMaria,et al.  Comparative effects of morphine, meperidine and pentazocine on cardiocirculatory dynamics in patients with acute myocardial infarction. , 1976, The American journal of medicine.

[8]  J. Rawles,et al.  Controlled trial of oxygen in uncomplicated myocardial infarction. , 1976, British medical journal.

[9]  G. Diamond,et al.  Correlative classification of clinical and hemodynamic function after acute myocardial infarction. , 1977, The American journal of cardiology.

[10]  J. Reves,et al.  Evidence for existence of intramyocardial steal. , 1977, Advances in experimental medicine and biology.

[11]  J. Cohn,et al.  Vasodilator therapy of cardiac failure (second of two parts). , 1977, The New England journal of medicine.

[12]  E. Chazov,et al.  Augmentation of Serum CPK Activity by Digitalis in Patients with Acute Myocardial Infarction , 1977, Circulation.

[13]  N. Reichek,et al.  Effect of diuresis on the performance of the failing left ventricle in man. , 1981, The American journal of medicine.

[14]  R. A. Johnson,et al.  Heart failure in outpatients: a randomized trial of digoxin versus placebo. , 1982, The New England journal of medicine.

[15]  K. Swedberg,et al.  Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction. , 1983, The American journal of cardiology.

[16]  D. Brater.  Resistance to Loop Diuretics , 1985, Drugs.

[17]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[18]  J. Heikkilä,et al.  Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. , 1985, The American journal of cardiology.

[19]  K. Swedberg,et al.  Hemodynamic effects of metoprolol in acute myocardial infarction. A randomized, placebo-controlled multicenter study. , 1985, The American journal of cardiology.

[20]  T. LeJemtel,et al.  Comparative systemic and renal effects of dopamine and angiotensin-converting enzyme inhibition with enalaprilat in patients with heart failure. , 1985, Circulation.

[21]  E. Braunwald,et al.  Inotropic stimulation of reperfused myocardium with dopamine: effects on infarct size and myocardial function. , 1985, Journal of the American College of Cardiology.

[22]  M. Bristow,et al.  Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. , 1986, Circulation.

[23]  E. Braunwald,et al.  New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1. , 1986, The New England journal of medicine.

[24]  E. Braunwald,et al.  New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. , 1986, The New England journal of medicine.

[25]  Katz Am.  Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. , 1986 .

[26]  E. Braunwald,et al.  Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. , 1986, Circulation.

[27]  A. Katz.  Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. , 1986, Circulation.

[28]  F. Schoen,et al.  Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. , 1987, Circulation.

[29]  C. Furberg.  Overview of completed sudden death trials: US experience. , 1987, Cardiology.

[30]  J. Alpert,et al.  A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. , 1987, Chest.

[31]  M. Böhm,et al.  Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. , 1988, European heart journal.

[32]  A. Tajik,et al.  Determination of left-sided pressure gradients by utilizing Doppler aortic and mitral regurgitant signals: validation by simultaneous dual catheter and Doppler studies. , 1988, Journal of the American College of Cardiology.

[33]  P. Ludmer,et al.  Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition. , 1988, The Journal of clinical investigation.

[34]  E. Antman,et al.  Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. , 1989, American heart journal.

[35]  U. Goldbourt,et al.  Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis of experience in 5,841 patients in the SPRINT Registry. SPRINT Study Group. , 1990, Chest.

[36]  M. Field,et al.  Metolazone in treatment of severe refractory congestive cardiac failure , 1990, The Lancet.

[37]  E. Marbán,et al.  Myocardial stunning and hibernation. The physiology behind the colloquialisms. , 1991, Circulation.

[38]  P. Marik,et al.  Acetazolamide in the treatment of metabolic alkalosis in critically ill patients. , 1991, Heart & lung : the journal of critical care.

[39]  A D Bersten,et al.  Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. , 1991, The New England journal of medicine.

[40]  J. López-Sendón,et al.  Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria. , 1992, Journal of the American College of Cardiology.

[41]  M. Lahav,et al.  Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. , 1992, Chest.

[42]  K. Swedberg,et al.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1992, The New England journal of medicine.

[43]  M. Gotsman,et al.  Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. , 1993, European heart journal.

[44]  G. Heusch,et al.  Development of Short‐term Myocardial Hibernation Its Limitation by the Severity of Ischemia and Inotropic Stimulation , 1993, Circulation.

[45]  E. Bennett,et al.  A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. , 1993, JAMA.

[46]  A. Adgey,et al.  Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. , 1993, Journal of the American College of Cardiology.

[47]  M. Packer,et al.  The development of positive inotropic agents for chronic heart failure: how have we gone astray? , 1993, Journal of the American College of Cardiology.

[48]  A. Timmis,et al.  Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. , 1993, BMJ.

[49]  K. Channer,et al.  Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial. , 1993, European heart journal.

[50]  A. Donker,et al.  Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. , 1993, The American journal of cardiology.

[51]  M. Metra,et al.  Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. , 1994, American heart journal.

[52]  R. Vagelos,et al.  Abnormalities of pulmonary function in patients with congestive heart failure, and reversal with ipratropium bromide. , 1994, The American journal of cardiology.

[53]  K. Channer,et al.  Combination diuretic treatment in severe heart failure: a randomised controlled trial. , 1994, British heart journal.

[54]  Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance , 1994, Journal of internal medicine.

[55]  H F Li,et al.  Quantitation of cardiac output with velocity-encoded, phase-difference magnetic resonance imaging. , 1995, The American journal of cardiology.

[56]  R. Hershberger,et al.  Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart. , 1995, Chest.

[57]  Dopaminergic Drugs in Congestive Heart Failure: Hemodynamic and Neuroendocrine Responses to Ibopamine, Dopamine, and Dihydroergotoxine , 1995, Journal of cardiovascular pharmacology.

[58]  B. Magnani,et al.  The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction , 1995 .

[59]  P. Agostoni,et al.  Lung-heart interaction as a substrate for the improvement in exercise capacity after body fluid volume depletion in moderate congestive heart failure. , 1995, The American journal of cardiology.

[60]  M. Cheitlin,et al.  Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up. , 1995, Chest.

[61]  S. Nagueh,et al.  Feasibility and accuracy of Doppler echocardiographic estimation of pulmonary artery occlusive pressure in the intensive care unit. , 1995, The American journal of cardiology.

[62]  B. Magnani,et al.  The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. , 1995, The New England journal of medicine.

[63]  R. Carney,et al.  A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. , 1995, The New England journal of medicine.

[64]  N. Sharpe,et al.  Beta-blockers in heart failure. Future directions. , 1996, European heart journal.

[65]  D. Brater,et al.  Pharmacodynamics of Torsemide Administered as an Intravenous Injection and as a Continuous Infusion to Patients with Congestive Heart Failure , 1996, Journal of clinical pharmacology.

[66]  F. Russel,et al.  Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. , 1996, Journal of the American College of Cardiology.

[67]  L. Goldman,et al.  The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. , 1996, JAMA.

[68]  L. Goldman,et al.  The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. , 1996, JAMA.

[69]  Johan Gabrielsson,et al.  Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration , 1996, Clinical pharmacology and therapeutics.

[70]  S. Chugh,et al.  Mechanisms and management of renal dysfunction in heart failure. , 1997, Current opinion in cardiology.

[71]  M. Janse,et al.  Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials , 1997, The Lancet.

[72]  D E Grobbee,et al.  The epidemiology of heart failure. , 1997, European heart journal.

[73]  G. Fonarow,et al.  Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. , 1997, Circulation.

[74]  K. Swedberg,et al.  Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Göteborg Metoprolol Trial). , 1997, The American journal of cardiology.

[75]  G. Fonarow,et al.  Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. , 1997, Journal of the American College of Cardiology.

[76]  A. Stäblein,et al.  Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure. , 1997, Journal of the American College of Cardiology.

[77]  H. Krumholz,et al.  Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age. , 1997, The American journal of cardiology.

[78]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[79]  G. Jay,et al.  Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. , 1997, Critical care medicine.

[80]  V. Fuster,et al.  Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. , 1997, Journal of the American College of Cardiology.

[81]  L. Tavazzi,et al.  Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function. , 1997, American heart journal.

[82]  Y. Moshkovitz,et al.  Increased toxicity of high‐dose furosemide versus low‐dose dopamine in the treatment of refractory congestive heart failure , 1997, Clinical pharmacology and therapeutics.

[83]  William A. Knaus,et al.  The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. , 1996, Journal of the American Medical Association (JAMA).

[84]  D. Chamberlain,et al.  The pre-hospital management of acute heart attacks. Recommendations of a Task Force of the The European Society of Cardiology and The European Resuscitation Council. , 1998, European heart journal.

[85]  S. Keenan,et al.  The effect of positive pressure airway support on mortality and the need for intubation in cardiogenic pulmonary edema: a systematic review. , 1998, Chest.

[86]  A. Sakamoto,et al.  Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. , 1998, Japanese circulation journal.

[87]  F. Follath.  Do diuretics differ in terms of clinical outcome in congestive heart failure? , 1998, European heart journal.

[88]  Z. Rumboldt,et al.  Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. , 1998, International journal of clinical pharmacology research.

[89]  S. Yusuf,et al.  Incidence, predictive factors and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure , 1998 .

[90]  W. Rand,et al.  Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.

[91]  R. Bolli.  Basic and clinical aspects of myocardial stunning. , 1998, Progress in cardiovascular diseases.

[92]  P. Shah,et al.  ACC expert consensus document. Present use of bedside right heart catheterization in patients with cardiac disease. American College of Cardiology. , 1998, Journal of the American College of Cardiology.

[93]  M C Oz,et al.  Implantable left ventricular assist devices. , 1998, The New England journal of medicine.

[94]  D. Brater.  Diuretic therapy. , 1998, The New England journal of medicine.

[95]  R. Gibbons,et al.  Present use of bedside right heart catheterization in patients with cardiac disease , 1998 .

[96]  P. Binkley,et al.  Parenteral inotropic support for advanced congestive heart failure. , 1998, Progress in cardiovascular diseases.

[97]  F. Zannad,et al.  Clinical definition and epidemiology of advanced heart failure. , 1998, American heart journal.

[98]  R. Gibbons,et al.  ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). , 1998, The Journal of heart valve disease.

[99]  H. Krumholz,et al.  Admission to hospitals with on-site cardiac catheterization facilities :impact on long-term costs and outcomes. , 1998, Circulation.

[100]  Y. Moshkovitz,et al.  Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema , 1998, The Lancet.

[101]  J. Monro,et al.  Postinfarction ventricular septal rupture: the Wessex experience. , 1998, Seminars in thoracic and cardiovascular surgery.

[102]  S. Vatner,et al.  Hibernating myocardium. , 1998, The New England journal of medicine.

[103]  R. Califf,et al.  Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). , 1999, American heart journal.

[104]  P. Mcdermott,et al.  Effect of ED management on ICU use in acute pulmonary edema. , 1999, The American journal of emergency medicine.

[105]  J S Alpert,et al.  1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) , 1999, Circulation.

[106]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[107]  H Wedel,et al.  Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .

[108]  S. Ommen,et al.  Dynamic left ventricular outflow tract obstruction in acute coronary syndromes: an important cause of new systolic murmur and cardiogenic shock. , 2000, Mayo Clinic proceedings.

[109]  A. Turpie,et al.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. , 1999, The New England journal of medicine.

[110]  I. Woods,et al.  Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery , 1999, BMJ.

[111]  B. Krämer,et al.  Diuretic treatment and diuretic resistance in heart failure. , 1999, The American journal of medicine.

[112]  L. Stevenson,et al.  Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. , 1999, American heart journal.

[113]  P. Marik.  Pulmonary artery catheterization and esophageal doppler monitoring in the ICU. , 1999, Chest.

[114]  S. Ball,et al.  Safety concerns about digoxin after acute myocardial infarction , 1999, The Lancet.

[115]  A. Sosnowski,et al.  Post infarction ventricular septal defect - can we do better? , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[116]  J. Younger,et al.  Extracorporeal life support: the University of Michigan experience. , 2000, JAMA.

[117]  A. Charlesworth,et al.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure. , 2000, Circulation.

[118]  Orton,et al.  INTRAVENOUS NESIRITIDE, A NATRIURETIC PEPTIDE, IN THE TREATMENT OF DECOMPENSATED CONGESTIVE HEART FAILURE , 2000 .

[119]  J. Cleland,et al.  Systematic review of the management of atrial fibrillation in patients with heart failure. , 2000, European heart journal.

[120]  J. O’Connell,et al.  The economic burden of heart failure , 2000, Clinical cardiology.

[121]  J. Masip,et al.  Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial , 2000, The Lancet.

[122]  R. Collins,et al.  Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab , 2000, Journal of the American College of Cardiology.

[123]  L. Sleeper,et al.  Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[124]  D. Behar,et al.  Long‐term prognosis of acute pulmonary oedema — an ominous outcome , 2000, European journal of heart failure.

[125]  A. Cohen-Solal,et al.  Treatment of Heart Failure With Celiprolol, a Cardioselective Beta Blocker With Beta-2 Agonist Vasodilatory Properties , 2000 .

[126]  J. Herlitz,et al.  Has an intensified treatment in the ambulance of patients with acute severe left heart failure improved the outcome? , 2000, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[127]  Z. Vered,et al.  High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. , 2000, Journal of the American College of Cardiology.

[128]  A. Cohen-Solal,et al.  Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group. , 2000, The American journal of cardiology.

[129]  C. Mazer,et al.  The Use of Transesophageal Echocardiography for Preload Assessment in Critically Ill Patients , 2000, Anesthesia and analgesia.

[130]  H. White,et al.  Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. , 2000, The American journal of medicine.

[131]  W. Stevenson,et al.  Catheter Ablation for Hemodynamically Unstable Monomorphic Ventricular Tachycardia , 2000, Journal of cardiovascular electrophysiology.

[132]  R. Lange,et al.  Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[133]  T. LeJemtel,et al.  Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. , 2000, The New England journal of medicine.

[134]  J. Calvin,et al.  The incidence of major morbidity in critically ill patients managed with pulmonary artery catheters: A meta‐analysis , 2000, Critical care medicine.

[135]  R. Califf,et al.  Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. , 2000, Circulation.

[136]  N. Ozdemir,et al.  Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography. , 2000, Journal of the American College of Cardiology.

[137]  H. Galley.  Renal-dose dopamine: will the message now get through? , 2000, The Lancet.

[138]  S. Gottlieb,et al.  Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure , 2000, Circulation.

[139]  H. White,et al.  Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[140]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.

[141]  M. Nieminen,et al.  Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. , 2000, Journal of the American College of Cardiology.

[142]  R. Cody,et al.  A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure. , 2001, Journal of cardiac failure.

[143]  A Haverich,et al.  Diagnosis and management of aortic dissection , 2001 .

[144]  L. Køber,et al.  Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy , 2001, Circulation.

[145]  G. Guyatt,et al.  Digitalis for treatment of congestive heart failure in patients in sinus rhythm. , 2001, The Cochrane database of systematic reviews.

[146]  M. Packer,et al.  Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. , 2001, Journal of cardiac failure.

[147]  K. Swedberg,et al.  Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.

[148]  R L Kormos,et al.  Mechanical cardiac support 2000: current applications and future trial design. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[149]  M. Bristow,et al.  Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. , 2001, International journal of cardiology.

[150]  B. Griffith,et al.  Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland. , 2001, Journal of the American College of Cardiology.

[151]  G. Fonarow.  The treatment targets in acute decompensated heart failure. , 2001, Reviews in cardiovascular medicine.

[152]  J. McMurray,et al.  Economics of chronic heart failure , 2001, European journal of heart failure.

[153]  D. Ellison.  Diuretic Therapy and Resistance in Congestive Heart Failure , 2002, Cardiology.

[154]  T. Levine,et al.  Dobutamine as bridge to angiotensin‐converting enzyme inhibitor‐nitrate therapy in endstage heart failure , 2001, Clinical cardiology.

[155]  D. Horstkotte,et al.  Management of prosthetic valve thrombosis , 2001 .

[156]  V. Fuster,et al.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation , 2001 .

[157]  W. Colucci,et al.  Nesiritide for the treatment of decompensated heart failure. , 2001, Journal of cardiac failure.

[158]  P. Krishnaswamy,et al.  Heart Failure/Transplant AbstractsUtility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting , 2001 .

[159]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[160]  Jeroen J. Bax,et al.  Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. , 2001, JAMA.

[161]  J. Ghali,et al.  Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure. , 2001, Circulation.

[162]  P. Poole‐Wilson,et al.  Coronary artery disease as the cause of incident heart failure in the population. , 2001, European heart journal.

[163]  R. Mehta,et al.  Clinical Benefit and Approach of Ultrafiltration in Acute Heart Failure , 2001, Cardiology.

[164]  D. Mann,et al.  Hemodynamic Effects of Tezosentan, an Intravenous Dual Endothelin Receptor Antagonist, in Patients With Class III to IV Congestive Heart Failure , 2001, Circulation.

[165]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[166]  J. Ghali,et al.  Acute Hemodynamic Effects of Conivaptan, a Dual V1A and V2 Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure , 2001 .

[167]  R. Califf,et al.  Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST. , 2001, American heart journal.

[168]  A. Handley,et al.  European Resuscitation Council Guidelines 2000 for Automated External Defibrillation. A statement from the Basic Life Support and Automated External Defibrillation Working Group(1) and approved by the Executive Committee of the European Resuscitation Council. , 2001, Resuscitation.

[169]  Judy W. M. Cheng,et al.  Fenoldopam in the Prevention of Contrast Media—Induced Acute Renal Failure , 2001, The Annals of pharmacotherapy.

[170]  Digitalis for treatment of congestive heart failure in patients in sinus rhythm. , 2001, The Cochrane database of systematic reviews.

[171]  P. Armstrong,et al.  A systematic review of randomized trials of disease management programs in heart failure. , 2001, The American journal of medicine.

[172]  Jeroen J. Bax,et al.  Predictors of Cardiac Events After Major Vascular Surgery Role of Clinical Characteristics, Dobutamine Echocardiography, and b-Blocker Therapy , 2001 .

[173]  D. Newby,et al.  Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations. , 2002, European heart journal.

[174]  G. Specchia,et al.  Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2002, European heart journal.

[175]  L. Reller,et al.  Diagnostic methods current best practices and guidelines for isolation of bacteria and fungi in infective endocarditis. , 2003, Infectious disease clinics of North America.

[176]  G. Breithardt,et al.  [Task Force on Sudden Cardiac Death, European Society of Cardiology. Summary of recommendations]. , 2002, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[177]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[178]  G. Breithardt,et al.  [Task Force on Sudden Cardiac Death, European Society of Cardiology. Summary of recommendations]. , 2002, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[179]  A. Handley,et al.  European Resuscitation Council Guidelines 2000 for Automated External Defibrillation. A statement from the Basic Life Support and Automated External Defibrillation Working Group(1) and approved by the Executive Committee of the European Resuscitation Council. , 2001, Resuscitation.

[180]  R. Califf,et al.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. , 2002, JAMA.

[181]  M. Metra,et al.  Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. , 2002, Journal of the American College of Cardiology.

[182]  J. Cleland,et al.  Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial , 2002, The Lancet.

[183]  M. Turina,et al.  Results of surgery for irreversible moderate to severe mitral valve regurgitation secondary to myocardial infarction. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[184]  Alan S Maisel,et al.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[185]  D. Raoult,et al.  Diagnostic methods current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. , 2002, Infectious disease clinics of North America.

[186]  T. LeJemtel,et al.  Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. , 2002, American heart journal.

[187]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[188]  M. Pfeffer,et al.  Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. , 2002, Journal of the American College of Cardiology.

[189]  A. Rhodes,et al.  A randomised, controlled trial of the pulmonary artery catheter in critically ill patients , 2002, Intensive Care Medicine.

[190]  N. Smedira,et al.  Mechanical circulatory assistance: state of art. , 2002, Circulation.

[191]  W. Hueston,et al.  Management of common arrhythmias: Part I. Supraventricular arrhythmias. , 2002, American family physician.

[192]  J. W. Schaeffer,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article , 2002 .

[193]  John A Spertus,et al.  Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. , 2002, Journal of the American College of Cardiology.

[194]  [Left ventricular free wall rupture during dobutamine stress echocardiography]. , 2002, Revista espanola de cardiologia.

[195]  J. Ghali,et al.  Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. , 2002, Journal of the American College of Cardiology.

[196]  S. Gottlieb,et al.  BG9719 (CVT-124), an A1 Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy , 2002, Circulation.

[197]  L. Stevenson,et al.  Medical management of advanced heart failure. , 2002, JAMA.

[198]  Rotura de la pared libre del ventrículo izquierdo durante prueba de estrés con dobutamina , 2002 .

[199]  C. O'connor,et al.  Diuretic resistance predicts mortality in patients with advanced heart failure. , 2002, American heart journal.

[200]  A. Maxwell,et al.  Influence of progressive renal dysfunction in chronic heart failure , 2002, European journal of heart failure.

[201]  B. Villari,et al.  Acetylcysteine and contrast agent-associated nephrotoxicity. , 2002, Journal of the American College of Cardiology.

[202]  N. Freemantle,et al.  The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure—a meta‐regression analysis , 2002, European journal of heart failure.

[203]  J. Cleland,et al.  Levosimendan: a new era for inodilator therapy for heart failure? , 2002, Current opinion in cardiology.

[204]  G. Marenzi,et al.  Marenzi, G. et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N. Engl. J. Med. 349, 1333-1340 , 2003 .

[205]  W. Colucci,et al.  Sustained Hemodynamic Effects of Intravenous Levosimendan , 2003, Circulation.

[206]  D. Sexton,et al.  Current best practices and guidelines. Assessment and management of complications in infective endocarditis. , 2002, Cardiology clinics.

[207]  L. Reller,et al.  Diagnostic methods. Current best practices and guidelines for isolation of bacteria and fungi in infective endocarditis. , 2002, Cardiology clinics.

[208]  A. Wagstaff,et al.  Levosimendan , 2012, Drugs.

[209]  L. Olaison,et al.  Current best practices and guidelines. Indications for surgical intervention in infective endocarditis. , 2002, Cardiology clinics.

[210]  L. Stevenson,et al.  Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. , 2003, Journal of the American College of Cardiology.

[211]  M. Nieminen,et al.  Clinical applications of B-type natriuretic peptide (BNP) testing. , 2003, European heart journal.

[212]  G. Marenzi,et al.  The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. , 2003, The New England journal of medicine.

[213]  Endocarditis prophylaxis yes: Endocarditis prophylaxis no , 2003, Clinical cardiology.

[214]  R. Brant,et al.  A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. , 2003, The New England journal of medicine.

[215]  D. Burkhoff,et al.  Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? , 2003, Circulation.

[216]  A. DeMaria,et al.  Fibrinolysis of mechanical prosthetic valve thrombosis: a single-center study of 127 cases. , 2003, Journal of the American College of Cardiology.

[217]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[218]  Frans Van de Werf,et al.  Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. , 2003 .

[219]  W. Grossman,et al.  Evaluation and Management of Diastolic Heart Failure , 2003, Circulation.

[220]  Silvia G Priori,et al.  ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co , 2003, Circulation.

[221]  J. Alpert.  The thrombosed prosthetic valve: current recommendations based on evidence from the literature. , 2003, Journal of the American College of Cardiology.

[222]  M. Gheorghiade,et al.  Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. , 2003, American heart journal.

[223]  N. Sharpe.  Beta blockers in heart failure , 1996, Heart Failure Reviews.

[224]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[225]  M. Böhm,et al.  Force-frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure , 1992, The clinical investigator.

[226]  J. Bourdarias,et al.  Invasive monitoring combined with two-dimensional echocardiographic study in septic shock , 1994, Intensive Care Medicine.